Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down per mutual agreement with the company. The company said Friday he ...

Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

The drug is set to be available on the NHS for weight loss soon, but one expert has flagged some potential risks that come with it.

WHEN Aimee Chapman began using fat jabs just over a year ago, she never expected to end up in hospital fighting for her life, ...

Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score matched ...